Here, we employ the use of the quadratic phenotypic optimization platform (QPOP) to characterize and narrow down effective combinations of targets which mediate the best possible treatment outcomes in MYC‐driven hepatocellular carcinoma (HCC) as our disease model of choice. The gene discussed is MYC; the disease is hepatocellular carcinoma.